{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:44:05Z","timestamp":1792147445628,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016981","name":"Necmettin Erbakan \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12012-026-10194-9","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:10:33Z","timestamp":1790759433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexpanthenol Attenuates Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-2767","authenticated-orcid":false,"given":"Durmu\u015f Ali","family":"Aslanlar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4102-1564","authenticated-orcid":false,"given":"Mustafa","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-2623","authenticated-orcid":false,"given":"Mehmet","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-0563","authenticated-orcid":false,"given":"Naile","family":"K\u00f6kbudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"10194_CR1","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat, P. S., Jaiswal, A., Khurana, A., et al. (2021). Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother Biomedecine Pharmacother, 139, 111708. https:\/\/doi.org\/10.1016\/j.biopha.2021.111708","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"10194_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","volume":"22","author":"M Sheibani","year":"2022","unstructured":"Sheibani, M., Azizi, Y., Shayan, M., et al. (2022). Doxorubicin-induced cardiotoxicity: An overview on pre-clinical therapeutic approaches. Cardiovascular Toxicology, 22, 292\u2013310. https:\/\/doi.org\/10.1007\/s12012-022-09721-1","journal-title":"Cardiovascular Toxicology"},{"key":"10194_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/clinpract11030064","volume":"11","author":"J Yoodee","year":"2021","unstructured":"Yoodee, J., Sookprasert, A., Sanguanboonyaphong, P., et al. (2021). An exploration of heart failure risk in breast cancer patients receiving anthracyclines with or without trastuzumab in Thailand: A retrospective study. Clinics and Practice, 11, 484\u2013493. https:\/\/doi.org\/10.3390\/clinpract11030064","journal-title":"Clinics and Practice"},{"key":"10194_CR4","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.2147\/DDDT.S469331","volume":"18","author":"F Gao","year":"2024","unstructured":"Gao, F., Xu, T., Zang, F., et al. (2024). Cardiotoxicity of anticancer drugs: Molecular mechanisms, clinical management and innovative treatment. Drug Design, Development and Therapy, 18, 4089\u20134116. https:\/\/doi.org\/10.2147\/DDDT.S469331","journal-title":"Drug Design, Development and Therapy"},{"key":"10194_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","volume":"18","author":"C-Y Kong","year":"2022","unstructured":"Kong, C-Y., Guo, Z., Song, P., et al. (2022). Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death. International Journal Of Biological Sciences, 18, 760\u2013770. https:\/\/doi.org\/10.7150\/ijbs.65258","journal-title":"International Journal Of Biological Sciences"},{"key":"10194_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137477","volume":"25","author":"R Vitale","year":"2024","unstructured":"Vitale, R., Marzocco, S., & Popolo, A. (2024). Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: A brief account. International Journal of Molecular Sciences, 25, Article 7477. https:\/\/doi.org\/10.3390\/ijms25137477","journal-title":"International Journal of Molecular Sciences"},{"key":"10194_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041320","volume":"27","author":"RA Syahputra","year":"2022","unstructured":"Syahputra, R. A., Harahap, U., Dalimunthe, A., et al. (2022). The role of flavonoids as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: A review. Molecules, 27, Article 1320. https:\/\/doi.org\/10.3390\/molecules27041320","journal-title":"Molecules"},{"key":"10194_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113788","volume":"146","author":"Y Hu","year":"2025","unstructured":"Hu, Y., Wang, S., Zhang, C., et al. (2025). Prx5 overexpression protect against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via the TLR4\/NF-\u03baB pathway. International Immunopharmacology, 146, Article 113788. https:\/\/doi.org\/10.1016\/j.intimp.2024.113788","journal-title":"International Immunopharmacology"},{"key":"10194_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.061","volume":"637","author":"P Feng","year":"2022","unstructured":"Feng, P., Yang, Y., Liu, N., & Wang, S. (2022). Baicalin regulates TLR4\/I\u03baB\u03b1\/NF\u03baB signaling pathway to alleviate inflammation in Doxorubicin related cardiotoxicity. Biochemical And Biophysical Research Communications, 637, 1\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.10.061","journal-title":"Biochemical And Biophysical Research Communications"},{"key":"10194_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121390","volume":"316","author":"AA Alzokaky","year":"2023","unstructured":"Alzokaky, A. A., Al-Karmalawy, A. A., Saleh, M. A., et al. (2023). Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1\/TLR4\/NLRP3 signaling pathway in mice. Life Sciences, 316, Article 121390. https:\/\/doi.org\/10.1016\/j.lfs.2023.121390","journal-title":"Life Sciences"},{"key":"10194_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cstres.2024.09.001","volume":"29","author":"Y Li","year":"2024","unstructured":"Li, Y., Yan, J., & Yang, P. (2024). The mechanism and therapeutic strategies in doxorubicin-induced cardiotoxicity: Role of programmed cell death. Cell Stress And Chaperones, 29, 666\u2013680. https:\/\/doi.org\/10.1016\/j.cstres.2024.09.001","journal-title":"Cell Stress And Chaperones"},{"key":"10194_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014638.pub2","author":"EC De Baat","year":"2022","unstructured":"De Baat, E. C., Mulder, R. L., Armenian, S., et al. (2022). Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines. Cochrane Database of Systematic Reviews. https:\/\/doi.org\/10.1002\/14651858.CD014638.pub2","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10194_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","volume":"25","author":"CK Tebbi","year":"2007","unstructured":"Tebbi, C. K., London, W. B., Friedman, D., et al. (2007). Dexrazoxane-Associated Risk for Acute Myeloid Leukemia\/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin\u2019s Disease. Journal Of Clinical Oncology, 25, 493\u2013500. https:\/\/doi.org\/10.1200\/JCO.2005.02.3879","journal-title":"Journal Of Clinical Oncology"},{"key":"10194_CR14","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/JCO.2007.11.8778","volume":"25","author":"SE Lipshultz","year":"2007","unstructured":"Lipshultz, S. E., Lipsitz, S. R., & Orav, E. J. (2007). Dexrazoxane-Associated Risk for Secondary Malignancies in Pediatric Hodgkin\u2019s Disease: A Claim Without Compelling Evidence. Journal Of Clinical Oncology, 25, 3179\u20133179. https:\/\/doi.org\/10.1200\/JCO.2007.11.8778","journal-title":"Journal Of Clinical Oncology"},{"key":"10194_CR15","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1200\/JCO.2007.12.6888","volume":"25","author":"K Hellmann","year":"2007","unstructured":"Hellmann, K. (2007). Dexrazoxane-Associated Risk for Secondary Malignancies in Pediatric Hodgkin\u2019s Disease: A Claim Without Evidence. Journal Of Clinical Oncology, 25, 4689\u20134690. https:\/\/doi.org\/10.1200\/JCO.2007.12.6888","journal-title":"Journal Of Clinical Oncology"},{"key":"10194_CR16","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1200\/JCO.2014.59.4473","volume":"33","author":"EJ Chow","year":"2015","unstructured":"Chow, E. J., Asselin, B. L., Schwartz, C. L., et al. (2015). Late Mortality After Dexrazoxane Treatment: A Report From the Children\u2019s Oncology Group. Journal Of Clinical Oncology, 33, 2639\u20132645. https:\/\/doi.org\/10.1200\/JCO.2014.59.4473","journal-title":"Journal Of Clinical Oncology"},{"key":"10194_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40959-019-0056-3","volume":"6","author":"J Li","year":"2020","unstructured":"Li, J., Chang, H-M., Banchs, J., et al. (2020). Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin. Cardio-Oncol, 6, 1. https:\/\/doi.org\/10.1186\/s40959-019-0056-3","journal-title":"Cardio-Oncol"},{"key":"10194_CR18","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.1002\/jcb.27058","volume":"119","author":"F Kalkan","year":"2018","unstructured":"Kalkan, F., Parlakpinar, H., Disli, O. M., et al. (2018). Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats. Journal of Cellular Biochemistry, 119, 7479\u20137489. https:\/\/doi.org\/10.1002\/jcb.27058","journal-title":"Journal of Cellular Biochemistry"},{"key":"10194_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101824","volume":"77","author":"A Yildiz","year":"2022","unstructured":"Yildiz, A., Demiralp, T., Vardi, N., et al. (2022). Protective effects of dexpanthenol in carbon tetrachloride-induced myocardial toxicity in rats. Tissue Cell, 77, Article 101824. https:\/\/doi.org\/10.1016\/j.tice.2022.101824","journal-title":"Tissue Cell"},{"key":"10194_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24007","volume":"10","author":"MS Ozcan","year":"2024","unstructured":"Ozcan, M. S., Savran, M., Kumbul Doguc, D., et al. (2024). Dexpanthenol ameliorates lipopolysaccharide-induced cardiovascular toxicity by regulating the IL-6\/HIF1\u03b1\/VEGF pathway. Heliyon, 10, Article e24007. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24007","journal-title":"Heliyon"},{"key":"10194_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4097\/kja.23207","volume":"76","author":"ES \u00d6zden","year":"2023","unstructured":"\u00d6zden, E. S., A\u015fc\u0131, H., B\u00fcy\u00fckbayram, H. \u0130, et al. (2023). Dexpanthenol protects against lipopolysaccharide-induced acute kidney injury by restoring aquaporin-2 levels via regulation of the silent information regulator 1 signaling pathway. Korean Journal of Anesthesiology, 76, 501\u2013509. https:\/\/doi.org\/10.4097\/kja.23207","journal-title":"Korean Journal of Anesthesiology"},{"key":"10194_CR22","doi-asserted-by":"publisher","first-page":"11625","DOI":"10.1080\/21655979.2022.2070585","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao, X., Zhang, S., & Shao, H. (2022). Dexpanthenol attenuates inflammatory damage and apoptosis in kidney and liver tissues of septic mice. Bioengineered, 13, 11625\u201311635. https:\/\/doi.org\/10.1080\/21655979.2022.2070585","journal-title":"Bioengineered"},{"key":"10194_CR23","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00210-023-02497-3","volume":"396","author":"MY Tepeba\u015f\u0131","year":"2023","unstructured":"Tepeba\u015f\u0131, M. Y., B\u00fcy\u00fckbayram, H. \u0130, \u00d6zmen, \u00d6., et al. (2023). Dexpanthenol ameliorates doxorubicin-induced lung injury by regulating endoplasmic reticulum stress and apoptosis. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 396, 1837\u20131845. https:\/\/doi.org\/10.1007\/s00210-023-02497-3","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10194_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012273","volume":"23","author":"DS Semenovich","year":"2022","unstructured":"Semenovich, D. S., Plotnikov, E. Y., Lukiyenko, E. P., et al. (2022). Protective effect of D-Panthenol in rhabdomyolysis-induced acute kidney injury. International Journal of Molecular Sciences, 23, Article 12273. https:\/\/doi.org\/10.3390\/ijms232012273","journal-title":"International Journal of Molecular Sciences"},{"key":"10194_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.3.6.3.4","volume":"2","author":"R Leonardi","year":"2007","unstructured":"Leonardi, R., & Jackowski, S. (2007). Biosynthesis of pantothenic acid and coenzyme A. EcoSal Plus, 2, Article 10.1128\/ecosalplus.3.6.3.4. https:\/\/doi.org\/10.1128\/ecosalplus.3.6.3.4","journal-title":"EcoSal Plus"},{"key":"10194_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie Du Sert","year":"2020","unstructured":"Percie Du Sert, N., Hurst, V., Ahluwalia, A., et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biology, 18, Article e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biology"},{"key":"10194_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2288-4-26","volume":"4","author":"M Saghaei","year":"2004","unstructured":"Saghaei, M. (2004). Random allocation software for parallel group randomized trials. Bmc Medical Research Methodology, 4, 26. https:\/\/doi.org\/10.1186\/1471-2288-4-26","journal-title":"Bmc Medical Research Methodology"},{"key":"10194_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.670479","volume":"12","author":"EY Podyacheva","year":"2021","unstructured":"Podyacheva, E. Y., Kushnareva, E. A., Karpov, A. A., & Toropova, Y. G. (2021). Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician. Frontiers in Pharmacology, 12, Article 670479. https:\/\/doi.org\/10.3389\/fphar.2021.670479","journal-title":"Frontiers in Pharmacology"},{"key":"10194_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10228-5","volume":"52","author":"MD Unlu","year":"2025","unstructured":"Unlu, M. D., Savran, M., Imeci, O., et al. (2025). The pantothenic acid derivative dexpanthenol ameliorated doxorubicin-induced neurotoxicity via regulating AKT\/CREB\/BDNF and AKT\/NRF2 signaling pathways. Molecular Biology Reports, 52, Article 228. https:\/\/doi.org\/10.1007\/s11033-025-10228-5","journal-title":"Molecular Biology Reports"},{"key":"10194_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M., & Ahmad, N. (2008). Dose translation from animal to human studies revisited. FASEB Journal, 22, 659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB Journal"},{"key":"10194_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/10520295.2021.1890215","volume":"97","author":"N P\u0131nar","year":"2022","unstructured":"P\u0131nar, N., Topalo\u011flu, M., Se\u00e7inti, \u0130E., et al. (2022). Protective effect of dexpanthenol on cisplatin induced nephrotoxicity in rats. Biotechnic & Histochemistry, 97, 39\u201343. https:\/\/doi.org\/10.1080\/10520295.2021.1890215","journal-title":"Biotechnic & Histochemistry"},{"key":"10194_CR32","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00210-023-02671-7","volume":"397","author":"MM \u00dcremi\u015f","year":"2024","unstructured":"\u00dcremi\u015f, M. M., G\u00fcrel, E., Aslan, M., & Ta\u015fl\u0131dere, E. (2024). Dexpanthenol protects against nicotine-induced kidney injury by reducing oxidative stress and apoptosis through activation of the AKT\/Nrf2\/HO-1 pathway. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 397, 1105\u20131114. https:\/\/doi.org\/10.1007\/s00210-023-02671-7","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10194_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.injury.2023.02.025","volume":"54","author":"P Kuru Bekta\u015fo\u011flu","year":"2023","unstructured":"Kuru Bekta\u015fo\u011flu, P., Koyuncuo\u011flu, T., \u00d6zayd\u0131n, D., et al. (2023). Antioxidant and neuroprotective effects of dexpanthenol in rats induced with traumatic brain injury. Injury, 54, 1065\u20131070. https:\/\/doi.org\/10.1016\/j.injury.2023.02.025","journal-title":"Injury"},{"key":"10194_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/10915818221124809","volume":"41","author":"LN Scott","year":"2022","unstructured":"Scott, L. N., Fiume, M., Bergfeld, W. F., et al. (2022). Safety assessment of panthenol, pantothenic acid, and derivatives as used in cosmetics. International Journal of Toxicology, 41, 77\u2013128. https:\/\/doi.org\/10.1177\/10915818221124809","journal-title":"International Journal of Toxicology"},{"key":"10194_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.117.032291","volume":"138","author":"F Schlotter","year":"2018","unstructured":"Schlotter, F., Halu, A., Goto, S., et al. (2018). Spatiotemporal multi-omics mapping generates a molecular atlas of the aortic valve and reveals networks driving disease. Circulation, 138, 377\u2013393. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032291","journal-title":"Circulation"},{"key":"10194_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001444","volume":"19","author":"NL Kikel-Coury","year":"2021","unstructured":"Kikel-Coury, N. L., Brandt, J. P., Correia, I. A., et al. (2021). Identification of astroglia-like cardiac nexus glia that are critical regulators of cardiac development and function. PLoS Biology, 19, Article e3001444. https:\/\/doi.org\/10.1371\/journal.pbio.3001444","journal-title":"PLoS Biology"},{"key":"10194_CR37","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.redox.2020.101582","volume":"36","author":"\u00c1 Viedma-Poyatos","year":"2020","unstructured":"Viedma-Poyatos, \u00c1., Pajares, M. A., & P\u00e9rez-Sala, D. (2020). Type III intermediate filaments as targets and effectors of electrophiles and oxidants. Redox Biology, 36, 101582. https:\/\/doi.org\/10.1016\/j.redox.2020.101582","journal-title":"Redox Biology"},{"key":"10194_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol, E. M., & Pekny, M. (2015). Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Current Opinion In Cell Biology, 32, 121\u2013130. https:\/\/doi.org\/10.1016\/j.ceb.2015.02.004","journal-title":"Current Opinion In Cell Biology"},{"key":"10194_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopha.2018.06.161","volume":"106","author":"M Kuzu","year":"2018","unstructured":"Kuzu, M., Kandemir, F. M., Yildirim, S., et al. (2018). Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomedicine & Pharmacotherapy, 106, 443\u2013453. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.161","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10194_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413567","volume":"25","author":"J Szponar","year":"2024","unstructured":"Szponar, J., Ciechanski, E., Ciechanska, M., et al. (2024). Evolution of theories on doxorubicin-induced late cardiotoxicity-role of topoisomerase. International Journal of Molecular Sciences, 25, Article 13567. https:\/\/doi.org\/10.3390\/ijms252413567","journal-title":"International Journal of Molecular Sciences"},{"key":"10194_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04715-1","volume":"21","author":"P Tai","year":"2023","unstructured":"Tai, P., Chen, X., Jia, G., et al. (2023). WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. Journal of Translational Medicine, 21, Article 823. https:\/\/doi.org\/10.1186\/s12967-023-04715-1","journal-title":"Journal of Translational Medicine"},{"key":"10194_CR42","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s11864-024-01238-9","volume":"25","author":"Z Kuang","year":"2024","unstructured":"Kuang, Z., Ge, Y., Cao, L., et al. (2024). Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review. Current Treatment Options In Oncology, 25, 1038\u20131054. https:\/\/doi.org\/10.1007\/s11864-024-01238-9","journal-title":"Current Treatment Options In Oncology"},{"key":"10194_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42760-4","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Guo, X., Zeng, Y., et al. (2023). Oxidative stress induces mitochondrial iron overload and ferroptotic cell death. Scientific Reports, 13, Article 15515. https:\/\/doi.org\/10.1038\/s41598-023-42760-4","journal-title":"Scientific Reports"},{"key":"10194_CR44","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1007\/s00204-023-03586-1","volume":"97","author":"A Reis-Mendes","year":"2023","unstructured":"Reis-Mendes, A., Ferreira, M., Duarte, J. A., et al. (2023). The role of inflammation and antioxidant defenses in the cardiotoxicity of doxorubicin in elderly CD-1 male mice. Archives of Toxicology, 97, 3163\u20133177. https:\/\/doi.org\/10.1007\/s00204-023-03586-1","journal-title":"Archives of Toxicology"},{"key":"10194_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-00955-5","volume":"19","author":"W Zhu","year":"2024","unstructured":"Zhu, W., Lian, N., Wang, J., et al. (2024). Liguzinediol potentiates the metabolic remodeling by activating the AMPK\/SIRT3 pathway and represses Caspase-3\/GSDME-mediated pyroptosis to ameliorate cardiotoxicity. Chinese Medicine, 19, Article 85. https:\/\/doi.org\/10.1186\/s13020-024-00955-5","journal-title":"Chinese Medicine"},{"key":"10194_CR46","doi-asserted-by":"publisher","first-page":"105366","DOI":"10.1016\/j.tiv.2022.105366","volume":"82","author":"L Zhou","year":"2022","unstructured":"Zhou, L., Han, Y., Yang, Q., et al. (2022). Scutellarin attenuates doxorubicin-induced oxidative stress, DNA damage, mitochondrial dysfunction, apoptosis and autophagy in H9c2 cells, cardiac fibroblasts and HUVECs. Toxicol Vitro Int J Publ Assoc BIBRA, 82, 105366. https:\/\/doi.org\/10.1016\/j.tiv.2022.105366","journal-title":"Toxicol Vitro Int J Publ Assoc BIBRA"},{"key":"10194_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1402138","volume":"15","author":"J Berlanga-Acosta","year":"2024","unstructured":"Berlanga-Acosta, J., Cibrian, D., Valiente-Mustelier, J., et al. (2024). Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms. Frontiers in Pharmacology, 15, Article 1402138. https:\/\/doi.org\/10.3389\/fphar.2024.1402138","journal-title":"Frontiers in Pharmacology"},{"key":"10194_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher, P., Beckman, J. S., & Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiological Reviews, 87, 315\u2013424. https:\/\/doi.org\/10.1152\/physrev.00029.2006","journal-title":"Physiological Reviews"},{"key":"10194_CR49","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.106.652339","volume":"116","author":"TG Neilan","year":"2007","unstructured":"Neilan, T. G., Blake, S. L., Ichinose, F., et al. (2007). Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin. Circulation, 116, 506\u2013514. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.652339","journal-title":"Circulation"},{"key":"10194_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12012-021-09710-w","volume":"22","author":"G Ibrahim Fouad","year":"2022","unstructured":"Ibrahim Fouad, G., & Ahmed, K. A. (2022). Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-\u03baB, and TNF-\u03b1 in Rats. Cardiovascular Toxicology, 22, 152\u2013166. https:\/\/doi.org\/10.1007\/s12012-021-09710-w","journal-title":"Cardiovascular Toxicology"},{"key":"10194_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111155","volume":"401","author":"MA Al-Ali","year":"2024","unstructured":"Al-Ali, M. A., Younis, N. S., Aldhubiab, B., et al. (2024). Anethole alleviates doxorubicin-induced cardiac and renal toxicities: Insights from network pharmacology and animal studies. Chemico-Biological Interactions, 401, Article 111155. https:\/\/doi.org\/10.1016\/j.cbi.2024.111155","journal-title":"Chemico-Biological Interactions"},{"key":"10194_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9120423","volume":"9","author":"V Quagliariello","year":"2022","unstructured":"Quagliariello, V., Basilicata, M. G., Pepe, G., et al. (2022). Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera improves cardiac functions and reduces pro-inflammatory biomarkers in preclinical models of short-term doxorubicin-mediated cardiotoxicity: New frontiers in cardioncology? Journal of Cardiovascular Development and Disease, 9, Article 423. https:\/\/doi.org\/10.3390\/jcdd9120423","journal-title":"Journal of Cardiovascular Development and Disease"},{"key":"10194_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121311","volume":"314","author":"FM Amin","year":"2023","unstructured":"Amin, F. M., Sharawy, M. H., Amin, M. N., et al. (2023). Nifuroxazide mitigates doxorubicin-induced cardiovascular injury: Insight into oxidative\/NLRP3\/GSDMD-mediated pyroptotic signaling modulation. Life Sciences, 314, Article 121311. https:\/\/doi.org\/10.1016\/j.lfs.2022.121311","journal-title":"Life Sciences"},{"key":"10194_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111151","volume":"125","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Zhang, D., Meng, T., et al. (2023). SGK1 is involved in doxorubicin-induced chronic cardiotoxicity and dysfunction through activation of the NF\u03baB pathway. International Immunopharmacology, 125, Article 111151. https:\/\/doi.org\/10.1016\/j.intimp.2023.111151","journal-title":"International Immunopharmacology"},{"key":"10194_CR55","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang, S., Liu, X., Bawa-Khalfe, T., et al. (2012). Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nature Medicine, 18, 1639\u20131642. https:\/\/doi.org\/10.1038\/nm.2919","journal-title":"Nature Medicine"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10194-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10194-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10194-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:28Z","timestamp":1792143988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10194-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10194"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10194-9","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the protocol was obtained from the Local Animal Experiment Ethics Committee of Necmettin Erbakan University (Konya, T\u00fcrkiye). (Decision Number: 2024-17, Approval date: Feb 27, 2024)","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"120"}}